beta
Text
1. The Plaintiff:
A. Defendant B is KRW 10,000,000 and annual 5% from December 29, 2008 to January 26, 2016.
Reasons
1. Basic facts
A. The parties’ status is the intention to operate the F Points of the E Hospital located in Gangdong-gu Seoul Metropolitan Government, and Defendant C is the representative of the E Hospital and the intention to operate the H Points of the E Hospital located in Seocho-gu Seoul Metropolitan Government.
B. During the course of treatment 1) The Plaintiff was diagnosed as per se in 1972 and was under treatment at around 2008, and was under treatment with the E Hospital I points around September 2008, the Plaintiff was from Defendant B, who had worked at the said point at the time, and was working at the said point on December 29, 2008 (hereinafter “the first operation”).
(2) Meanwhile, Defendant B inserted NAFF into the bones of the Plaintiff’s mouth for the purpose of cutting down and correcting the static frame in the process of the above high-tech surgery. (2) After the first operation, the Plaintiff was subject to her heavy pain, and was released on January 23, 2009, and was released on January 23, 2009.
Since then, 6 weeks' necks and tin-to-bells are also subject to rehabilitation treatment, but they are unable to walk well, and the pains continued.
3) The Plaintiff: (a) had been engaged in nuclear medical examination at the astronomical Matern Hospital of the Nansung University on July 13, 2009; (b) had been diagnosed as an operation of the right frame or an additional nuclear medical examination network after surgery; and (c) had been found to be the result of the examination, but Defendant B did not perform an additional nuclear medical examination; (d) had been unable to walk properly and continued pain; and (e) on January 19, 2010, Defendant C conducted the MRI inspection on the Plaintiff’s right mouth; and (e) had been said to have been divided into the mouth and the bones attached to the bones.
5) Thereafter, on February 23, 2010, the Plaintiff’s breathing and fluoral fluoral fluoral fluoring (hereinafter referred to as “the second 2th fluoral fluoring”).